dipyridamole has been researched along with Cell Transformation, Viral in 1 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Cell Transformation, Viral: An inheritable change in cells manifested by changes in cell division and growth and alterations in cell surface properties. It is induced by infection with a transforming virus.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Palú, G | 1 |
| Handschumacher, RE | 1 |
| Parolin, C | 1 |
| Stefanelli, S | 1 |
| Palatini, P | 1 |
1 other study available for dipyridamole and Cell Transformation, Viral
| Article | Year |
|---|---|
Effect of herpes simplex virus type 1 infection on nucleoside transport in HeLa S3 cells.
Topics: Affinity Labels; Biological Transport; Cell Transformation, Viral; Dipyridamole; HeLa Cells; Humans; | 1990 |